Letter to the Editor

Vol. 26 No. 3 (2015): Turkish Journal of Gastroenterology

Development of hypocalcemia with telaprevir-based triple treatment in a case of genotype 1 chronic hepatitis C

Main Article Content

Ebubekir Şenateş
Yaşar Çolak
Atakan Yeşil
İlyas Tuncer

Abstract

Hepatitis C virus (HCV) is a major public health problem and a leading cause of chronic liver disease. Telaprevir is a protease inhibitor used to treat chronic hepatitis C in combination with Peg-interferon (IFN)-α2a+ribavirin (PR) (1); however, it has numerous side effects (2).

Article Details

Most read articles by the same author(s)

1 2 3 > >>